[HTML][HTML] Biological mechanisms underpinning the development of long COVID
As COVID-19 evolves from a pandemic to an endemic disease, the already staggering
number of people that have been or will be infected with SARS-CoV-2 is only destined to …
number of people that have been or will be infected with SARS-CoV-2 is only destined to …
Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study
Summary Background Characterizing Post-Acute Sequelae of COVID (SARS-CoV-2
Infection), or PASC has been challenging due to the multitude of sub-phenotypes, temporal …
Infection), or PASC has been challenging due to the multitude of sub-phenotypes, temporal …
[HTML][HTML] Risk factors and clinical presentations of long COVID in Africa: A scoping review.
E Moyo, M Chimene, P Moyo, G Musuka… - Journal of Infection and …, 2023 - Elsevier
ABSTRACT COVID-19-related complications can last for years, even in patients who are
asymptomatic during the acute phase, a phenomenon referred to as long COVID. This …
asymptomatic during the acute phase, a phenomenon referred to as long COVID. This …
Autoantibodies to interferons in infectious diseases
E Quiros-Roldan, A Sottini, SG Signorini, F Serana… - Viruses, 2023 - mdpi.com
Anti-cytokine autoantibodies and, in particular, anti-type I interferons are increasingly
described in association with immunodeficient, autoimmune, and immune-dysregulated …
described in association with immunodeficient, autoimmune, and immune-dysregulated …
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial
LN Geng, H Bonilla, H Hedlin, KB Jacobson… - JAMA Internal …, 2024 - jamanetwork.com
Importance There is an urgent need to identify treatments for postacute sequelae of SARS-
CoV-2 infection (PASC). Objective To assess the efficacy of a 15-day course of nirmatrelvir …
CoV-2 infection (PASC). Objective To assess the efficacy of a 15-day course of nirmatrelvir …
Meta-analysis of the impact of physical activity on the recovery of physical function in COVID-19 patients
G Yang, Z Li, Z Li, L Huang, P Liang, L Liu, D Li - Heliyon, 2023 - cell.com
Background The decrease in physical function resulting from COVID-19 infection exerts a
substantial negative influence on the quality of life of individuals. Physical activity plays a …
substantial negative influence on the quality of life of individuals. Physical activity plays a …
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
G Amadoro, V Latina, E Stigliano, A Micera - Cells, 2023 - mdpi.com
A growing body of evidence indicates that a neuropathological cross-talk takes place
between the coronavirus disease 2019 (COVID-19)-the pandemic severe pneumonia that …
between the coronavirus disease 2019 (COVID-19)-the pandemic severe pneumonia that …
Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study
Objective To determine if patients that develop lingering neurologic symptoms of fatigue and
“brain fog” after initial recovery from coronavirus disease 2019 (COVID-19) have persistent …
“brain fog” after initial recovery from coronavirus disease 2019 (COVID-19) have persistent …
The predictors of long COVID in southeastern Italy
VN Quaranta, A Portacci, S Dragonieri… - Journal of Clinical …, 2023 - mdpi.com
Introduction: Long COVID is now recognized as a common consequence of the SARS-CoV-
2 infection, but we are still far from fully understanding its pathogenesis and predictive …
2 infection, but we are still far from fully understanding its pathogenesis and predictive …
Hypothesis: inflammatory acid-base disruption underpins Long Covid
V van der Togt, JS Rossman - Frontiers in Immunology, 2023 - frontiersin.org
The mechanism of Long Covid (Post-Acute Sequelae of COVID-19; PASC) is currently
unknown, with no validated diagnostics or therapeutics. SARS-CoV-2 can cause …
unknown, with no validated diagnostics or therapeutics. SARS-CoV-2 can cause …